Follow-up and outcomes for resection of colorectal liver metastases in Edinburgh

European Journal of Surgical Oncology

Volumn 33, Issue 1, 2007, Pages 55-60

  Connor, S ^a   Hart, M G ^a   Redhead, D N ^a   Ireland, H ^a   Madhavan, K K ^a   Parks, R W ^a   Garden, O J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Audit; Carcinoembryonic antigen (CEA); Colorectal cancer; Hepatic metastases; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; COLON RESECTION; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; UNITED KINGDOM; VISCERAL METASTASIS;

AGED; COLORECTAL NEOPLASMS; ENGLAND; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREVALENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33846397152     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.09.017     Document Type: Article

References (35)

1. Choti M.A., Sitzman J.V., Tiburi M.F., et al. Trends in long term survival following liver resection for hepatic colorectal metastases. Ann Surg 235 (2002) 759-766
2. Nordlinger B., Vallant J.C., Guiget M., et al. Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. J Clin Oncol 12 (1994) 1491-1496
3. Yamada H., Kondo S., Okushiba S., Morikawa T., and Katoh H. Analysis of predictive factors for recurrence after hepatic resection. World J Surg 25 (2001) 1129-1133
4. Crowe P.J., Yang J.L., Berney C.R., et al. Genetic markers of survival and liver recurrence after resection of liver metastases for colorectal cancer. World J Surg 25 (2001) 996-1001
5. Mala T., Bohler G., Mathisen O., Bergan A., and Soriede O. Hepatic resection for colorectal metastases: can pre-operative scoring predict patient outcome?. World J Surg 26 (2002) 1348-1353
6. Figueras J., Valls C., Rafeeas A., Fabregat J., Ramos E., and Jaurrieta E. Resection rate and effect of post-operative chemotherapy on survival after surgery for colorectal liver metastases. Br J Sug 88 (2001) 980-985
7. Ambiru S., Miyazaki M., Isono T., et al. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum (1999) 632-639
8. Wang J.Y., Chiang J.M., Jeng L.B., Changchien C.R., Chen J.S., and Hsu K.C. Resection of liver metastases from colorectal cancer: are there any truly significant clinical prognosticators?. Dis Colon Rectum 39 (1996) 847-851
9. Rees M., Plant G., and Bygrave S. Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 84 (1997) 1136-1140
10. Wannebo H.J., Chu Q.D., Vezeridids M.P., and Soderburg C. Patient selection for hepatic resection of colorectal metastases. Arch Surg 131 (1996) 322-329
11. Sasaki A., Aramaki M., Kawano K., Yasuda K., Inomata M., and Kitano S. Prognostic significance of intrahepatic lymphatic invasion in patients with hepatic resection due to metastases form colorectal carcinoma. Cancer 95 (2002) 105-111
12. Schlag P., Hohenberger P., and Herfarth C. Resection of liver metastases in colorectal cancer: competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 16 (1990) 360-365
13. Scheele J., Stangi R., Altendorf-Hofmann A., and Gall F.P. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110 (1991) 13-29
14. Bakalakos E.A., Burak Jr. W.E., Young D.C., and Martin Jr. E.W. Is carcinoembryonic antigen useful in the follow up management of patients with colorectal liver metastases?. Am J Surg 177 (1991) 2-6
15. Goldberg R.M., Fleming T.R., Tangen C.M., et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success after resection. Ann Intern Med 19 (1998) 27-35
16. Maughan T.S., James R.D., Kerr D.J., et al. Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. Lancet 359 (2002) 1555-1563
17. Cunningham D., Pyrhonen S., James R.D., et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 352 (1998) 1413-1418
18. Scheithauer W., Rosen H., Kornek G.V., Sebesta C., and Depisch D. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 306 (1993) 752-755
19. Fortner J.G. Recurrence of colorectal cancer after hepatic resection. Am J Surg 155 (1988) 378-382
20. Holm A., Bradley E., and Aldrete J.S. Hepatic resection of metastasis from colorectal carcinoma: morbidity, mortality and pattern of recurrence. Ann Surg 209 (1989) 428-434
21. Hughes K.S., Simon R., Songhorabodi S., et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of the patterns of recurrence. Surgery 100 (1986) 278-284
22. Steele Jr. G., Osteen R.T., Wilson R.E., et al. Patterns of failure after surgical cure of large liver tumours: a change in the proximate cause of death and a need for effective systemic adjuvant therapy. Am J Surg 147 (1984) 554-559
23. Bozzetti F., Doci R., Bignami P., Morabito A., and Gennari L. Patterns of failure following surgical resection for colorectal cancer liver metastases: rationale for a multimodal approach. Ann Surg 205 (1987) 264-270
24. Yamaguchi J., Komuta K., Matsuzaki S., Okudaira S., Fujioka H., and Kanematsu T. Mode of infiltrative growth of colorectal liver metastases is a useful predictor of recurrence after hepatic resection. World J Surg 26 (2002) 1122-1125
25. Petrowsky H., Gonen M., Jarningin W., et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 235 (2002) 863-871
26. Metcalfe M.S., Mullin E.J., and Maddern G.J. Choice of surveillance after hepatectomy for colorectal metastases. Arch Surg 139 (2004) 749-754
27. Gill S., and Goldberg R.M. First-line treatment strategies to improve survival in patients with advanced colorectal cancer. Drugs 64 (2004) 27-44
28. Simmonds P.C. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 321 (2000) 531-535
29. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. J Clin Oncol 10 (1992) 904-911
30. Moran B.J., O'Rourke N., Plant G.R., and Rees M. Computed tomographic portography in preoperative imaging of hepatic neoplasms. Br J Surg 82 (1995) 669-671
31. Kondo H., Kanematsu M., Hoshi H., et al. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT. AJR Am J Roentgenol 174 (2000) 947-954
32. Strasberg S.M., Dehdashti F., Siegel B.A., Drebin J.A., and Linehan D. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Ann Surg 233 (2001) 293-299
33. Laurent C., Sa Cunha A., Rullier E., Smith D., Rullier A., and Saric J. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis. J Am Coll Surg 198 (2004) 884-891
34. Yamamoto J., Shimada K., Kosuge T., Yamasaki S., Sakamoto M., and Fukuda H. Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg 86 (1999) 332-337
35. Schindl M., Wigmore S.J., Currie E.J., Leangle F., and Garden O.J. Prognostic scoring in colorectal cancer liver metastases. Arch Surg 140 (2005) 1-7